Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease

Journal of the Chinese Medical Association

Volumn 71, Issue 11, 2008, Pages 551-558

  Chen, Shi Ming ^a   Liu, Chieh Yu ^b   Li, Shian Rei ^a   Huang, Hui Ting ^a   Tsai, Ching Ten ^a   Jou, Hei Jen ^a  

^a TAIWAN ADVENTIST HOSPITAL   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

Lifestyle program; Nonalcoholic fatty liver disease; Spinning exercise

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HIP CIRCUMFERENCE; HUMAN; INSULIN SENSITIVITY; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LOW CALORY DIET; MALE; NONALCOHOLIC FATTY LIVER; PROSPECTIVE STUDY; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 57149123017     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70168-0     Document Type: Article

References (30)

1. Fan JG, Peng YD. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int 2007;6:572-8.
2. Kim Hae-J, Kim Hyeong-J, Lee KY, Kim SK, Ahn CW, Lim SK, Kim KR, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 165:2169-75.
3. Duvnjak M, Lerotic I, Barosic N, Tomasic V, Jukic V, Velagic V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol 2007;13:4539-50.
4. Lorenzo C, Serrano-Ríos M, Martínez-Larrad MT, González-Sánchez JL, Seclén S, Villena A, Gonzalez-Villalpando C, et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetes subjects. Diabetes Care 2006;29:404-9.
5. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos Nutrition and Liver Study. Hepatology 2005;42:508-14.
6. Amanrapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL, Asia-Pacific Working Party on NAFLD. How common is non-alcoholic fatty liver in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007;22:788-93.
7. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of non-alcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsy. Hepatol 2005; 42:132-8.
8. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol 2007;22:1482-9.
9. Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006;82:315-22.
10. Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, Emick D, et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005; 100:1072-81.
11. Okita M, Hayashi M, Sasagawa T, Takagi K, Suzuki B, Ito T, Yamada G. Effect of a moderately energy-restricted diet on obese patients with fatty liver. Nutrition 2001;17:542-7.
12. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, Torimura T, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997;27:103-7.
13. Suzuki A, Lindor K, St. Saver J, Lymp J, Mendes F, Muto A, Okada T, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005;43: 1060-6.
14. Stewart KJ, Bacher AC, Turner K, Lim JG, Hees PS, Shapiro EP, Tayback M, et al. Exercise and risk factors associated with metabolic syndrome in older adults. Am J Pre Med 2005;28: 9-18.
15. Thomas EL, Brynes AE, Hamilton G, Patel N, Spong A, Goldin RD, Frost G, et al. Effect of nutritional counseling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol 2006;12:5813-9.
16. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990; 99:1408-13.
17. Yang PM, Huang GT, Lin JT, Shen JC, Lai MY, Su IJ, Hsu HC, et al. Ultrasonography in the diagnosis of benign diffuse parenchymal liver disease: a prospective study. J Formosan Med Assoc 1988;87:966-77.
18. Silvia V, Nicoletta P, Diego A, Daniele DR, Filippo N, Francesca S, Lucilla M, et al. Dietary glycemic index and liver steatosis. Am J Clin Nutr 2006;84:136-42.
19. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986;292:13-5.
20. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
21. Cortez-Pinto H, Camilo ME. Non-alcoholic fatty liver disease/ non-alcoholic fatty liver disease steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract Res Clin Gastroenterol 2004;18:1089-104.
22. Liang KY, Zeger SL. Longitudinal data analysis using general linear models. Biometrika 1986;73:13-22.
23. McCullagh P. Regression models for ordinal data (with discussion). J R Stat Soc B 1980;42:109-42.
24. Sreenivasa Baba C, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A, Choudhuri G. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2006; 21:191-8.
25. Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G, Esposito A, Belloni E, et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 2007;30:683-8.
26. Tamura Y, Tanaka Y, Sato F, Choi JB, Watada H, Niwa M, Kinoshita J, et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2005;90: 3191-6.
27. Jennings GL, Nelson L, Nestel P, Korner P, Burton D, Bazelmans J. The effects of changes in physical activity on major cardiovascular risk factors, haemodynamics, sympathetic function and glucose utilization in man: a controlled study of 4 levels of activity. Circulation 1986;73:30-40.
28. Cox KL, Burke V, Morton AR, Beilin LJ, Puddey IB. Independent and additive effects of energy restriction and exercise on glucose and insulin concentrations in sedentary overweight men. Am J Clin Nutr 2004:80:308-16.
29. Katzel LI, Blecker ER, Colman EG, Rogus EM, Sorkin JD, Goldberg AP. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy obese, middle-aged and older men: randomized controlled trial. JAMA 1995;274:1915-21.
30. Lessard SJ, Rivas DA, Chen ZP, Bonen A, Febbraio MA, Reeder DW, Kemp BE, et al. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance. Diabetes 2007;56:1856-64.